People · Operator
Named in public records as an officer, director or promoter · active 2011–2018 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Soliton, Inc. | — | Other | Series A | $25.3M | $143.0M | 2018 |
| Peloton Therapeutics, Inc. | — | Biotechnology | Series A | $13.7M | $423.0M | 2011 |
Brett RIngle at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brett RIngle on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Brown | 1 | 34 |
| David Goeddel | 1 | 10 |
| Tim Kutzkey | 1 | 7 |
| John Creecy | 1 | 5 |
| Jonathan Foster | 1 | 5 |
| Walter V Klemp | 1 | 3 |
| Dennis K. Stone | 1 | 3 |
| John Josey | 1 | 3 |
| Walter Klemp | 1 | 3 |
| John Elwood | 1 | 2 |
| Joe V. Tanner | 1 | 2 |
| Christopher Capelli | 1 | 1 |
| Danika Harrison | 1 | 1 |
| Bradley Hauser | 1 | 1 |
| Lori Bisson | 1 | 1 |
| Lori C. Bisson | 1 | 1 |
| Joe C. Tanner | 1 | 1 |
| Brett A. Ringle | 1 | 1 |
| Lee C. Stranathan | 1 | 1 |
| Christopher C. Capelli | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.